Insider trades

Bennett C. Frank, Chief Officer of Ionis Pharmaceuticals IONS, has filed 0 purchases and 24 sales on the open market. Over the past 12 months that comes to a net sale of $15M. The latest trade was on 03/03.

Bennett C. Frank

EVP, Chief Scientific Officer
First filing
23/03/02
Trades
77 trades
Buys / sales
0 / 24
12-month net buying
−$15M
Last trade
03/03

Trading activity

Transactions

Trade type
IONS
Open-market sale10b5-1 plan03/0303/0585,089 sh3 trades$79.23avg.$6,741,767.08−51.4%
IONS
Open-market sale10b5-1 plan02/0202/0485,089 sh3 trades$82.93avg.$7,056,339.67−51.4%
Open-market sale01/3002/025,885 sh$82.95$488,160.75−5.5%
Open-market sale01/1601/208,977 sh$75.15$674,621.55−8.7%
Open-market sale10b5-1 plan25/09/0525/09/096,000 sh$59.60$357,600−6.8%
IONS
Open-market sale10b5-1 plan25/09/02–25/09/0325/09/0438,909 sh2 trades$59.14avg.$2,301,263.58−27.7%
Open-market sale10b5-1 plan25/08/1825/08/2010,000 sh$43.98$439,800−9.7%
Open-market sale25/01/3125/02/031,327 sh$32.46$43,074.42−1.4%
Open-market sale25/01/1625/01/176,752 sh$32.90$222,140.8−6.9%
Open-market saleAmendment24/02/0224/09/041,885 sh$49.52$93,345.2−2.3%
Open-market sale24/02/0224/02/021,853 sh$49.52$91,760.56−2.3%
Open-market sale24/01/1724/01/186,745 sh$50.42$340,082.9−8.0%
IONS
Open-market sale10b5-1 plan23/12/20–23/12/2123/12/2222,613 sh2 trades$49.39avg.$1,116,869.77−25.6%
IONS
Open-market sale10b5-1 plan23/12/1423/12/1822,612 sh2 trades$49.58avg.$1,121,174.32−25.6%
Open-market sale10b5-1 plan23/09/2823/09/294,460 sh$46.50$207,390−6.4%
Open-market sale23/02/0623/02/071,813 sh$40.57$73,553.41−2.5%
Open-market sale23/01/1823/01/196,978 sh$38.89$271,374.42−9.3%